logo
搜索
菜单

Transmissi的搜索结果

当前1/5页
排序: 本周浏览数
9.9: Characteristics of Series Resonant Circuit 01:24 min
9.9: Characteristics of Series Resonant Circuit
8.11: Reducing Line Loss 01:18 min
8.11: Reducing Line Loss
8.10: Line Loss 01:10 min
8.10: Line Loss
8.6: The Delta-to-Delta Circuit 01:17 min
8.6: The Delta-to-Delta Circuit
8.2: Generation of Three-Phase Voltage 01:21 min
8.2: Generation of Three-Phase Voltage
8.1: Three-Phase Circuits 01:22 min
8.1: Three-Phase Circuits
7.9: The Maximum Power Transfer Theorem 01:20 min
7.9: The Maximum Power Transfer Theorem
6.10: Mesh Analysis for AC Circuits 01:12 min
6.10: Mesh Analysis for AC Circuits
16.10: Ligand-gated Ion Channels 01:19 min
16.10: Ligand-gated Ion Channels
16.20: Chemical Synapses 01:26 min
16.20: Chemical Synapses
6.10: Tension 01:10 min
6.10: Tension
7.8: Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin 01:26 min
7.8: Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
7.3: Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action 01:17 min
7.3: Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
6.17: Drugs Affecting Neurotransmitter Release or Uptake 01:21 min
6.17: Drugs Affecting Neurotransmitter Release or Uptake
6.1: Adrenergic Neurons: Neurotransmission 01:27 min
6.1: Adrenergic Neurons: Neurotransmission
5.24: Drugs Acting on Autonomic Ganglia: Blockers 01:28 min
5.24: Drugs Acting on Autonomic Ganglia: Blockers
5.18: Myasthenia Gravis: Diagnostic Tests 01:15 min
5.18: Myasthenia Gravis: Diagnostic Tests
5.17: Myasthenia Gravis: Overview and Treatment 01:20 min
5.17: Myasthenia Gravis: Overview and Treatment
5.15: Indirect-Acting Cholinergic Agonists: Pharmacological Actions 01:30 min
5.15: Indirect-Acting Cholinergic Agonists: Pharmacological Actions
5.4: Cholinergic Neurons: Neurotransmission 01:23 min
5.4: Cholinergic Neurons: Neurotransmission
返回顶部